Cargando…
Prevalence and risk factors of chronic kidney disease in an HIV positive Mexican cohort
BACKGROUND: HIV subjects have several kidney pathologies, like HIV-associated nephropathy or antiretroviral therapy injury, among others. The global prevalence of Chronic Kidney Disease (CKD) is 8–16%; however, in HIV subjects, the prevalence varies between geographic regions (2–38%). The aim was to...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461868/ https://www.ncbi.nlm.nih.gov/pubmed/34556049 http://dx.doi.org/10.1186/s12882-021-02526-4 |
_version_ | 1784572077161840640 |
---|---|
author | Valdivia-Cerda, Verónica Alvarez-Zavala, Monserrat Sánchez-Reyes, Karina Cabrera-Silva, Rodolfo I. Ruiz-Herrera, Vida V. Loza-Salazar, Aldo D. Martínez-Ayala, Pedro Vázquez-Limón, Juan C. García-García, Guillermo Andrade-Villanueva, Jaime F. González-Hernández, Luz A. |
author_facet | Valdivia-Cerda, Verónica Alvarez-Zavala, Monserrat Sánchez-Reyes, Karina Cabrera-Silva, Rodolfo I. Ruiz-Herrera, Vida V. Loza-Salazar, Aldo D. Martínez-Ayala, Pedro Vázquez-Limón, Juan C. García-García, Guillermo Andrade-Villanueva, Jaime F. González-Hernández, Luz A. |
author_sort | Valdivia-Cerda, Verónica |
collection | PubMed |
description | BACKGROUND: HIV subjects have several kidney pathologies, like HIV-associated nephropathy or antiretroviral therapy injury, among others. The global prevalence of Chronic Kidney Disease (CKD) is 8–16%; however, in HIV subjects, the prevalence varies between geographic regions (2–38%). The aim was to determine the prevalence of CKD and identify the associated risk factors. METHODS: A longitudinal descriptive study was carried out at the 'Hospital Civil de Guadalajara' Feb'18 – Jan'19. Basal clinical, demographic, opportunistic infections (OI), and laboratory data were obtained at months 0 and 3; inclusion criteria were ≥ 18 years old, naïve HIV + , urine albumin/creatinine ratio, serum creatinine & urine test, and signed informed consent. Descriptive and multiple logistic regression statistical analyses were made. RESULTS: One hundred twenty subjects were included; 92.5% were male, 33 ± 9.5 years, 60% consumed tobacco, 73% alcohol, and 59% some type of drug. The CKD prevalence was 15.8%. CKD patients had a higher risk of hepatitis C virus coinfection, Relative Risk (RR):5.9; HCV infection, RR:4.3; ≥ 30 years old, RR:3.9; C clinical-stage, RR:3.5; CD4(+) T cells count < 200 cells/μL, RR: 2.4; and HIV-1 viral load ≥ 100,000 cop/mL, RR: 2.7. CONCLUSIONS: Our study showed a higher CKD prevalence in patients with HIV; higher CKD development with coinfections as Hepatitis C Virus and Mycobacterium tuberculosis. The identification and prompt management of CKD and coinfections should be considered to avoid the progression and to delay renal replacement therapy as long as possible. |
format | Online Article Text |
id | pubmed-8461868 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84618682021-09-24 Prevalence and risk factors of chronic kidney disease in an HIV positive Mexican cohort Valdivia-Cerda, Verónica Alvarez-Zavala, Monserrat Sánchez-Reyes, Karina Cabrera-Silva, Rodolfo I. Ruiz-Herrera, Vida V. Loza-Salazar, Aldo D. Martínez-Ayala, Pedro Vázquez-Limón, Juan C. García-García, Guillermo Andrade-Villanueva, Jaime F. González-Hernández, Luz A. BMC Nephrol Research BACKGROUND: HIV subjects have several kidney pathologies, like HIV-associated nephropathy or antiretroviral therapy injury, among others. The global prevalence of Chronic Kidney Disease (CKD) is 8–16%; however, in HIV subjects, the prevalence varies between geographic regions (2–38%). The aim was to determine the prevalence of CKD and identify the associated risk factors. METHODS: A longitudinal descriptive study was carried out at the 'Hospital Civil de Guadalajara' Feb'18 – Jan'19. Basal clinical, demographic, opportunistic infections (OI), and laboratory data were obtained at months 0 and 3; inclusion criteria were ≥ 18 years old, naïve HIV + , urine albumin/creatinine ratio, serum creatinine & urine test, and signed informed consent. Descriptive and multiple logistic regression statistical analyses were made. RESULTS: One hundred twenty subjects were included; 92.5% were male, 33 ± 9.5 years, 60% consumed tobacco, 73% alcohol, and 59% some type of drug. The CKD prevalence was 15.8%. CKD patients had a higher risk of hepatitis C virus coinfection, Relative Risk (RR):5.9; HCV infection, RR:4.3; ≥ 30 years old, RR:3.9; C clinical-stage, RR:3.5; CD4(+) T cells count < 200 cells/μL, RR: 2.4; and HIV-1 viral load ≥ 100,000 cop/mL, RR: 2.7. CONCLUSIONS: Our study showed a higher CKD prevalence in patients with HIV; higher CKD development with coinfections as Hepatitis C Virus and Mycobacterium tuberculosis. The identification and prompt management of CKD and coinfections should be considered to avoid the progression and to delay renal replacement therapy as long as possible. BioMed Central 2021-09-23 /pmc/articles/PMC8461868/ /pubmed/34556049 http://dx.doi.org/10.1186/s12882-021-02526-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Valdivia-Cerda, Verónica Alvarez-Zavala, Monserrat Sánchez-Reyes, Karina Cabrera-Silva, Rodolfo I. Ruiz-Herrera, Vida V. Loza-Salazar, Aldo D. Martínez-Ayala, Pedro Vázquez-Limón, Juan C. García-García, Guillermo Andrade-Villanueva, Jaime F. González-Hernández, Luz A. Prevalence and risk factors of chronic kidney disease in an HIV positive Mexican cohort |
title | Prevalence and risk factors of chronic kidney disease in an HIV positive Mexican cohort |
title_full | Prevalence and risk factors of chronic kidney disease in an HIV positive Mexican cohort |
title_fullStr | Prevalence and risk factors of chronic kidney disease in an HIV positive Mexican cohort |
title_full_unstemmed | Prevalence and risk factors of chronic kidney disease in an HIV positive Mexican cohort |
title_short | Prevalence and risk factors of chronic kidney disease in an HIV positive Mexican cohort |
title_sort | prevalence and risk factors of chronic kidney disease in an hiv positive mexican cohort |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461868/ https://www.ncbi.nlm.nih.gov/pubmed/34556049 http://dx.doi.org/10.1186/s12882-021-02526-4 |
work_keys_str_mv | AT valdiviacerdaveronica prevalenceandriskfactorsofchronickidneydiseaseinanhivpositivemexicancohort AT alvarezzavalamonserrat prevalenceandriskfactorsofchronickidneydiseaseinanhivpositivemexicancohort AT sanchezreyeskarina prevalenceandriskfactorsofchronickidneydiseaseinanhivpositivemexicancohort AT cabrerasilvarodolfoi prevalenceandriskfactorsofchronickidneydiseaseinanhivpositivemexicancohort AT ruizherreravidav prevalenceandriskfactorsofchronickidneydiseaseinanhivpositivemexicancohort AT lozasalazaraldod prevalenceandriskfactorsofchronickidneydiseaseinanhivpositivemexicancohort AT martinezayalapedro prevalenceandriskfactorsofchronickidneydiseaseinanhivpositivemexicancohort AT vazquezlimonjuanc prevalenceandriskfactorsofchronickidneydiseaseinanhivpositivemexicancohort AT garciagarciaguillermo prevalenceandriskfactorsofchronickidneydiseaseinanhivpositivemexicancohort AT andradevillanuevajaimef prevalenceandriskfactorsofchronickidneydiseaseinanhivpositivemexicancohort AT gonzalezhernandezluza prevalenceandriskfactorsofchronickidneydiseaseinanhivpositivemexicancohort |